Sign in
CompletedNo phase

Low Nicotine Cigarettes Plus Electronic Cigarettes

Key facts

Who runs it
Milton S. Hershey Medical Center
Where
Hershey, United StatesSee the site
Trial code
Status
Completed
People taking part
88 people enrolled
Started
1 Jun 2021
Ended
12 Aug 2024
Type of study
Interventional, 4 groups
Treatments tested
  • Normal Nicotine Content research cigarettes
  • High Nicotine e-cigarette
  • Very Low Nicotine Content research cigarettes
  • Zero Nicotine e-cigarette
Record updated
11 September 2025

Who can take part

Age
21 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 26 criteriaShow less

Who can take part

  • Smoke >5 cigarettes per day for at least the prior 12 months
  • Smoke regular, filtered cigarettes or machine-rolled cigarettes with a filter
  • Exhaled CO measurement of ≥ 6 parts per million at baseline
  • No serious cigarette smoking quit attempt or use of any FDA-approved smoking cessation medication in the prior 30 days (includes any nicotine replacement, varenicline, bupropion [used specifically as a quitting aid])
  • No plans to quit smoking within the next 3 weeks
  • Must be willing to both switch to a different type of cigarette that may contain a different amount of nicotine and to try an e-cig to substitute for some of their cigarettes
  • Must be willing and able to respond to contacts from study staff or attend visits over the study period (not planning to move, not planning extended vacation, no planned surgeries)
  • 9. Must meet lifetime diagnostic criteria for a current or lifetime unipolar or bipolar mood disorder (e.g. major depressive disorder, major depressive episode, manic episode, hypomanic episode, bipolar disorder), an anxiety disorder (e.g. panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, , agoraphobia, social anxiety disorder, generalized anxiety disorder), a psychotic disorder (e.g. mood disorder or other psychotic disorder), or an eating disorder (e.g. anorexia or bulimia) based on the MINI-International Neuropsychiatric Interview Standard (MINI) (version 7.0.2)
  • Able to read and write in English
  • Able to understand and give informed consent
  • Access to a computer/smartphone with e-mail and a reliable internet connection

Who cannot take part

  • Use of marijuana or other illegal drugs/prescription drugs for non-medical use daily/almost daily or weekly in the past 3 months per NIDA Quick Screen
  • Surgery requiring general anesthesia in the past 6 weeks
  • Previous use of SPECTRUM research cigarettes in the past 6 months
  • Currently taking or have taken medications prescribed to prevent seizures (such as Carbamazepine or Phenobarbital). Using seizure medications for off-label use (indications other than treatment for seizures) will not be included as an exclusion, these will be assessed on a case-by-case basis
  • Unstable or significant medical condition in the past 3 months (e.g., recent heart attack or other serious heart condition, stroke, severe angina, high blood pressure [systolic >159 mmHg or diastolic >99 mmHg during screening)
  • Respiratory diseases (e.g., exacerbations of asthma or COPD, require oxygen, require oral prednisone), kidney (e.g., dialysis) or liver disease (e.g., cirrhosis), severe immune system disorders (e.g., uncontrolled HIV/AIDS, multiple sclerosis symptoms) or any medical disorder/medication that may affect participant safety or biomarker data
  • Uncontrolled mental illness or substance abuse, or inpatient treatment for these in the past 6 months
  • Any known allergy to propylene glycol or vegetable glycerin
  • History of a seizure disorder or had a seizure in the past 12 months
  • Women who are pregnant and/or nursing or trying to become pregnant
  • Current suicide risk on clinical assessment (above "low risk" score (or ≥ 9) on MINI diagnostic interview suicide module during screening (34))
  • Use of any non-cigarette nicotine delivery product (e.g., pipe, cigar, dip, chew, snus, hookah, e-cig, strips or sticks, IQOS) in the past 7 days at screening
  • Use of an e-cig for 5 or more days in the past 28 days or any use in the past 7 days at screening
  • Unwilling to remain on one flavor of cigarette (regular or menthol) for the duration of the trial
  • Other member of household currently participating in the study

Where in United States

  • Penn State College of MedicineHershey, United States

About the trial

What the trial wants to find out

This study aims to determine the health effects of very low nicotine content in cigarettes, in conjunction with the availability of nicotine-containing electronic cigarettes (e-cigs) among smokers with mental health conditions (SMHC).

The 4 groups in the trial

  • NNC cigarettes + High Nicotine Containing E-cigaretteTreatment being tested

    Participants are provided with normal nicotine content (NNC) cigarettes (11.6 mg nicotine/cigarette) plus e-cigarette with high nicotine e-liquid.

    Treatment: Normal Nicotine Content research cigarettes and High Nicotine e-cigarette

  • NNC cigarettes + Zero Nicotine Containing E-cigaretteTreatment being tested

    Participants are provided with normal nicotine content (NNC) cigarettes (11.6 mg nicotine/cigarette) plus e-cigarette with zero nicotine e-liquid.

    Treatment: Normal Nicotine Content research cigarettes and Zero Nicotine e-cigarette

  • VLNC cigarettes + High Nicotine Containing E-cigaretteTreatment being tested

    Participants are provided with very low nicotine content (VLNC) cigarettes (0.2 mg nicotine/cigarette) plus e-cigarette with high nicotine e-liquid.

    Treatment: High Nicotine e-cigarette and Very Low Nicotine Content research cigarettes

  • VLNC cigarettes + Zero Nicotine Containing E-cigaretteTreatment being tested

    Participants are provided with very low nicotine content (VLNC) cigarettes (0.2 mg nicotine/cigarette) plus e-cigarette with zero nicotine e-liquid

    Treatment: Very Low Nicotine Content research cigarettes and Zero Nicotine e-cigarette

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized Trial of Low Nicotine Cigarettes Plus Electronic Cigarettes in Smokers
Record updated
11 September 2025